Timothy Alexander

Recovery Centers of America at Devon Joins Ambetter Network to Expand Access to Addiction Treatment DEVON, PA — Recovery Centers of America (RCA) at Devon has announced a pivotal step in its mission to combat substance use disorder by securing an i […]

Hyperion Biosystems and Colorcon Partner to Combat Counterfeit Pharmaceuticals WATERTOWN, MA & HARLEYSVILLE, PA — Hyperion Biosystems and Colorcon have announced a licensing agreement aimed at revolutionizing the fight against c […]

ProRx Pharma Partners with Gatlan to Revolutionize Men's Health EXTON, PA — ProRx Pharma has announced an exclusive partnership with Gatlan, a men’s health brand founded by actor and director Josh Duhamel. This co […]

Eggs Redefined: FDA Declares Them ‘Healthy’ in a Game-Changing Move for Your Plate MALVERN, PA — The U.S. Food and Drug Administration (FDA) has officially labeled eggs as a “healthy food,” following an updated definition that e […]

Citadel Credit Union Becomes SBA Lender, Boosting Support for Philadelphia’s Small Businesses EXTON, PA — Citadel Credit Union has achieved authorization as an official Small Business Administration (SBA) lender, marking a pivotal milestone in i […]

Mallinckrodt and Endo Advance Key Milestones in Strategic Merger DUBLIN, Ireland & MALVERN, PA — Mallinckrodt plc and Endo, Inc. (OTCQX: NDOI) have announced significant steps forward in their proposed merger aimed a […]

UHS CFO Steve Filton to Present at Major 2025 Healthcare Conferences KING OF PRUSSIA, PA — Universal Health Services, Inc. (NYSE: UHS) announced that Steve Filton, Executive VP and CFO, will speak at upcoming h […]

Can You Afford Rent in 2025? Rising Costs Are Pushing the Limit for Millions SEATTLE, WA — Renters across the United States are facing a sharp rise in income requirements to afford housing, according to a new analysis by Z […]

Penske Unveils Enhanced Catalyst AI to Revolutionize Fleet Intelligence READING, PA — Penske Truck Leasing has introduced a groundbreaking update to Catalyst AI™, its proprietary artificial intelligence platform des […]

EFC Gases Secures NASA Contract to Advance Xenon Gas Reprocessing HATFIELD, PA — EFC Gases & Advanced Materials has been awarded a prestigious five-year contract by NASA to support its xenon gas reprocessing needs. T […]

Havis Unveils Innovative Docking Station for Zebra ET6X Tablets WARMINSTER, PA — Havis, Inc. has introduced the SDS-ZEB-504, a stationary docking station specifically designed for Zebra ET6X Tablets, including the E […]

Onfolio Holdings Reports Q1 2025 Growth and Strategic Progress WILMINGTON, DE — Onfolio Holdings Inc. (NASDAQ: ONFO, ONFOW) (OTC: ONFOP) highlighted significant revenue and operational improvements in its Q1 2025 f […]

Windtree Therapeutics Reports Q1 2025 Financial Results and Strategic Milestones WARRINGTON, PA — Windtree Therapeutics, Inc. (NasdaqCM: WINT) has announced its first-quarter 2025 financial results and shared updates on its s […]

Globus Medical Announces $500M Share Repurchase Program to Boost Shareholder Value AUDUBON, PA — Globus Medical, Inc. (NYSE: GMED) announced that its Board of Directors has authorized a share repurchase program of up to $500 million o […]

Historic Treasure Trove Unveiled: Rare Coins & Gold Bar Go to No-Reserve Auction DENVER, PA — Morphy Auctions is set to host its highly anticipated Premier Coins Auction on May 19, featuring an extraordinary single-consignor c […]

Century Therapeutics Reports Positive Q1 2025 Results and Advances in Cell Therapy Pipeline PHILADELPHIA, PA — Century Therapeutics, Inc. (NASDAQ: IPSC) reported notable progress in Q1 2025, emphasizing advancements in its clinical and p […]

CORA Group Announces Beth McCoy as President of CORA Loyalty WARMINSTER, PA — CORA Group has announced the promotion of Beth McCoy to President of CORA Loyalty, where she will now oversee the company’s loy […]

Palvella Therapeutics Reports Q1 2025 Financials and Clinical Progress WAYNE, PA — Palvella Therapeutics, Inc. (Nasdaq: PVLA) has released its financial results for the first quarter of 2025, along with key updates from i […]

Cabaletta Bio Updates Progress on RESET-Myositis Trial and Regulatory Milestones PHILADELPHIA, PA — Cabaletta Bio, Inc. (Nasdaq: CABA) has announced key updates on its RESET-Myositis trial and plans for the anticipated 2027 B […]

Traws Pharma Highlights Q1 2025 Financial Progress and Antiviral Developments NEWTOWN, PA — Traws Pharma, Inc. (NASDAQ: TRAW) has reported its first-quarter financial results and provided updates on its investigational a […]